-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LlW686XqHhGCVYHC+/58VWF/dG3ue+/R/ZllMIwx/xfYWyUHgMJNg/UzSzzGH/tv
 VfzW8b3z3mFNNL+plwBaZw==

<SEC-DOCUMENT>0001140361-10-033342.txt : 20100813
<SEC-HEADER>0001140361-10-033342.hdr.sgml : 20100813
<ACCEPTANCE-DATETIME>20100813160658
ACCESSION NUMBER:		0001140361-10-033342
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20100811
FILED AS OF DATE:		20100813
DATE AS OF CHANGE:		20100813

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			TAYLOR RICHMOND L
		CENTRAL INDEX KEY:			0001217565

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10670
		FILM NUMBER:		101015429

	MAIL ADDRESS:	
		STREET 1:		4155 E LAPALMA AVE SUITE 400
		CITY:			ANEHEIM
		STATE:			CA
		ZIP:			92807

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HANGER ORTHOPEDIC GROUP INC
		CENTRAL INDEX KEY:			0000722723
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
		IRS NUMBER:				840904275
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		TWO BETHESDA METRO CENTER
		STREET 2:		SUITE 1300
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
		BUSINESS PHONE:		3019860701

	MAIL ADDRESS:	
		STREET 1:		TWO BETHESDA METRO CENTER
		STREET 2:		SUITE 1300
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SEQUEL CORP
		DATE OF NAME CHANGE:	19890814

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELLTECH COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19860304
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc1.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2010-08-11</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000722723</issuerCik>
        <issuerName>HANGER ORTHOPEDIC GROUP INC</issuerName>
        <issuerTradingSymbol>HGR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001217565</rptOwnerCik>
            <rptOwnerName>TAYLOR RICHMOND L</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>TWO BETHESDA METRO CENTER, SUITE 1200</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>BETHESDA</rptOwnerCity>
            <rptOwnerState>MD</rptOwnerState>
            <rptOwnerZipCode>20814</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Executive Vice President</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2010-08-11</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>4324</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>14.4012</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>56559</value>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes>
        <footnote id="F1">The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares.</footnote>
        <footnote id="F2">These shares were sold at a range of sale prices from $14.37 to $14.44.  The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.</footnote>
        <footnote id="F3">Includes (i) unvested restricted shares which total 5,750 shares of stock from an initial grant of 5,750 shares of restricted stock made on March 30, 2010; (ii) unvested restricted shares and fully vested shares that total 22,676 shares of stock from an initial grant of 24,948 shares of restricted stock and performance shares made on November 13, 2008; (iii) unvested restricted shares that total 18,176 shares of stock from an initial grant of 45,000 shares of restricted stock and performance shares made on August 9, 2007; (iv) fully vested shares that total 6,260 shares of stock from an initial grant of 40,000 shares of restricted stock made on June 12, 2006; and (v) 3,697 shares of stock that were derived from previous grants of restricted shares that are now fully vested. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Teri L. Champ, Attorney-in-Fact for Richmond L. Taylor</signatureName>
        <signatureDate>2010-08-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----